QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders
This author has yet to write their bio.Meanwhile lets just say that we are proud ysalledechou contributed a whooping 2 entries.
Entries by ysalledechou
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Did you know that women compose about two thirds of AD dementia patients ? One hormone could explain why.… https://t.co/xyESvPXCcN5 days ago
- Focus on early AD and MCI detection in the primary care setting is key. Technology such as screening platforms, com… https://t.co/TEQ8eaQasP17 days ago
- The incidence of #dementia is rapidly increasing. How much do you know about the four syndromes that account for mo… https://t.co/alo8b1aE4v19 days ago
- Interesting article to understand the neurobiology of #COVID19 neurological complications and the implications for… https://t.co/xMgwjyIbKS22 days ago
130, rue de Lourmel
75015 Paris – France